MICHAEL MITCHELL: Open Payments
NPI 1144953837 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 60 payments from 19 companies in 2025. Trend: 2023 $1,680 · 2024 $1,458 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $175 |
| AstraZeneca Pharmaceuticals LP | 3 | $171 |
| ABBVIE INC. | 11 | $136 |
| PFIZER INC. | 5 | $81 |
| Abbott Laboratories | 4 | $79 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Novo Nordisk Inc | 3 | $45 |
| Astellas Pharma US Inc | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Dexcom, Inc. | 2 | $43 |
Products named: FARXIGA, MOUNJARO, VRAYLAR, JARDIANCE, PREVNAR 20, FREESTYLE LIBRE 3, Ozempic, Veozah.
Industry payments across OK — which companies pay providers there.
